Edge Wealth Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Edge Wealth Management's ADPT Position: Q3 2026 in Review
Edge Wealth Management reduced its Adaptive Biotechnologies (ADPT) stake by 3.3% in Q3 2026, selling an estimated $73.7K and leaving 87,000 shares worth $2.53M. The position accounts for 0.38% of the portfolio, ranked #31.
Edge Wealth Management first reported a position in ADPT in Q1 2020 and has held it in 27 quarters since. The position peaked at $5.3M in Q4 2020. 34 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.
- Edge Wealth Management held 87,000 shares of Adaptive Biotechnologies worth $2.53M as of Q3 2026.
- Edge Wealth Management sold 3,000 Adaptive Biotechnologies shares in Q3 2026, an estimated $73.7K.
- Adaptive Biotechnologies made up 0.38% of Edge Wealth Management's portfolio in Q3 2026, its #31 holding.
- Edge Wealth Management first reported a position in Adaptive Biotechnologies in Q1 2020 and has held it in 27 quarters since.
- Edge Wealth Management's Adaptive Biotechnologies position peaked at $5.3M in Q4 2020.
- 34 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.
Based on Edge Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.